Abstract
In brief The UK probably underestimates the prevalence of medical errors, which might now be the third leading cause of death in the USA Prescriptions for attention deficit hyperactivity disorder drugs increased by almost 800% between 2000 and 2015 Varenicline and bupropion do not seem to increase the risk of neuropsychiatric adverse events compared to nicotine patches or placebo; varenicline is more effective at helping patients quit than placebo, nicotine patches and bupropion Some studies associate sulfonylureas with cardiovascular events, but a new meta-analysis is reassuring
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
